FindTrial
Sign In

Left heart decompression during extracorporeal membrane oxygenation for cardiogenic shock: hemodynamic effects and impacts on cardiac and pulmonary function

Left heart decompression during extracorporeal membrane oxygenation for cardiogenic shock: hemodynamic effects and impacts on cardiac and pulmonary function

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300072357
Enrollment
Unknown
Registered
2023-06-12
Start date
2023-06-12
Completion date
Unknown
Last updated
2023-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiogenic shock

Interventions

ECMO combined and non combined LHD:None

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: From January 1, 2012 to May 31, 2025, patients admitted to West China Hospital on VA-ECMO support with indications of left ventricular decompression.

Exclusion criteria

Exclusion criteria: ? The cause of initiation of VA-ECMO is not cardiogenic shock; ? The patient's family members refused to participate in the trial program.

Design outcomes

Primary

MeasureTime frame
Death in hospital;—

Secondary

MeasureTime frame
Myocardial recovery;ECMO was successfully evacuated;Mechanical ventilation time;Length of ICU stay;Hospitalization cost;—

Countries

China

Contacts

Public ContactPeng Ji

West China Hospital, Sichuan University

drpengji@wchscu.cn+86 189 8060 0867

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026